VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 356 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $6,000 | -14.3% | 391 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $7,000 | +75.0% | 391 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $4,000 | -55.6% | 391 | -36.5% | 0.00% | -33.3% |
| Q4 2016 | $9,000 | -75.0% | 616 | -58.5% | 0.00% | -76.9% |
| Q3 2016 | $36,000 | +9.1% | 1,486 | -8.8% | 0.01% | -18.8% |
| Q2 2016 | $33,000 | -5.7% | 1,629 | +22.6% | 0.02% | +6.7% |
| Q1 2016 | $35,000 | – | 1,329 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |